Levothyroxine Sodium Tablet
Product Images NDC 71335-1499

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 71335-1499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Levothyroixe Molecule (Levothyroxine Molecule)
Chemical structure of Levothyroxine Sodium, showing the arrangement of iodine atoms, phenyl rings, and functional groups including an amino group, carboxylate sodium salt, and associated water molecule.*
FDA Label Image

Label (Lbl713351499)

Label (Lbl713351499)
Label for Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) oral tablets. The label states a quantity of 30 tablets and includes storage instructions to keep at 25°C with permitted excursions, protect from light and moisture, and keep out of reach of children. It shows repackaging by Bryant Ranch Prepack, Inc. and manufacturing by Neolpharma, Inc. The National Drug Code (NDC) 71335-1499-1 is prominently displayed along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.